InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Jason P Rhodes, Director, is a corporate insider tracked by InsiderTape across 2 companies. The public record shows 35 open-market SEC Form 4 transactions: 1 purchase worth $10.0M and 34 sales worth $74.3M, reported from Sep 22, 21 to Jul 7, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 7, 26 | DYNDyne Therapeutics, Inc. | SELL | 124.4K | $23.62 | $2.9M |
| Jul 6, 26 | DYNDyne Therapeutics, Inc. | SELL | 253.0K | $22.79 | $5.8M |
| Jun 29, 26 | DYNDyne Therapeutics, Inc. | SELL | 103.0K | $21.14 | $2.2M |
| Jun 26, 26 | DYNDyne Therapeutics, Inc. | SELL | 163.0K | $21.28 | $3.5M |
| Jun 25, 26 | DYNDyne Therapeutics, Inc. | SELL | 12.7K | $21.10 | $268K |
| Jun 24, 26 | DYNDyne Therapeutics, Inc. | SELL | 50.5K | $21.02 | $1.1M |
| Jun 23, 26 | DYNDyne Therapeutics, Inc. | SELL | 77.9K | $21.13 | $1.6M |
| May 6, 26 | DYNDyne Therapeutics, Inc. | SELL | 43.6K | $18.18 | $793K |
| May 5, 26 | DYNDyne Therapeutics, Inc. | SELL | 6.1K | $18.03 | $110K |
| May 4, 26 | DYNDyne Therapeutics, Inc. | SELL | 6.2K | $18.00 | $112K |
| Apr 28, 26 | DYNDyne Therapeutics, Inc. | SELL | 119.1K | $19.00 | $2.2M |
| Apr 27, 26 | DYNDyne Therapeutics, Inc. | SELL | 90.9K | $18.15 | $1.7M |
| Apr 24, 26 | DYNDyne Therapeutics, Inc. | SELL | 72.3K | $18.48 | $1.3M |
| Apr 23, 26 | DYNDyne Therapeutics, Inc. | SELL | 38.3K | $19.19 | $735K |
| Apr 22, 26 | DYNDyne Therapeutics, Inc. | SELL | 150.9K | $19.68 | $3.0M |
| Apr 21, 26 | DYNDyne Therapeutics, Inc. | SELL | 142.3K | $20.05 | $2.8M |
| Apr 20, 26 | DYNDyne Therapeutics, Inc. | SELL | 142.6K | $20.06 | $2.9M |
| Nov 14, 24 | DYNDyne Therapeutics, Inc. | SELL | 583 | $33.10 | $19K |
| Mar 1, 24 | DYNDyne Therapeutics, Inc. | SELL | 29.4K | $30.05 | $885K |
| Feb 28, 24 | DYNDyne Therapeutics, Inc. | SELL | 152.2K | $25.25 | $3.8M |
| Feb 27, 24 | DYNDyne Therapeutics, Inc. | SELL | 272.9K | $24.68 | $6.7M |
| Feb 26, 24 | DYNDyne Therapeutics, Inc. | SELL | 136.3K | $23.98 | $3.2M |
| Feb 23, 24 | DYNDyne Therapeutics, Inc. | SELL | 159.5K | $22.70 | $3.6M |
| Feb 22, 24 | DYNDyne Therapeutics, Inc. | SELL | 119.4K | $22.66 | $2.7M |
| Feb 21, 24 | DYNDyne Therapeutics, Inc. | SELL | 149.3K | $23.14 | $3.4M |
| Feb 20, 24 | DYNDyne Therapeutics, Inc. | SELL | 166.0K | $23.40 | $3.8M |
| Feb 16, 24 | DYNDyne Therapeutics, Inc. | SELL | 162.7K | $23.14 | $3.8M |
| Feb 15, 24 | DYNDyne Therapeutics, Inc. | SELL | 175.8K | $24.45 | $4.2M |
| Dec 12, 22 | DYNDyne Therapeutics, Inc. | BUY | 934.6K | $10.70 | $10.0M |
| Sep 29, 21 | GBIOGeneration Bio Co. | SELL | 16.6K | $24.59 | $407K |
| Sep 28, 21 | GBIOGeneration Bio Co. | SELL | 13.1K | $25.24 | $330K |
| Sep 27, 21 | GBIOGeneration Bio Co. | SELL | 51.3K | $25.70 | $1.3M |
| Sep 24, 21 | GBIOGeneration Bio Co. | SELL | 28.9K | $25.84 | $746K |
| Sep 23, 21 | GBIOGeneration Bio Co. | SELL | 75.3K | $26.55 | $2.0M |
| Sep 22, 21 | GBIOGeneration Bio Co. | SELL | 30.6K | $25.89 | $791K |